Presented positive interim data through 52 weeks and beyond for 4D-150 in wet AMD from PRISM Phase 1/2 clinical trial highlighting robust and ...

Selenium supplementation does not seem to add benefits to patients with Graves ophthalmopathy who live in already selenium-sufficient areas.

Radhakrishnan noted that the awareness of dry eye in glaucoma patients had been increasing, and the availability of more ...

Your half-century mark is more than just a milestone birthday celebration. Preventive steps now can help you roar into your ...

We asked ophthalmologists what stands out to them in the history of treating glaucoma and where future treatments might be heading.

Moorfields Eye Hospital Dubai today announced that it has been awarded “Center of Excellence” accreditation in ophthalmology ...

Because price and margin headwinds exist predominantly in small-molecule oral tablets that are easy to produce, we expect Viatris’ future pipeline to focus more on complex generics—drugs that have ...

At the conference, NurExone will present preclinical results demonstrating significant optic nerve regeneration – a promising treatment pathway for glaucoma and other eye diseases. The presentation ...

Optic neuropathy and recurrence of papilledema in patients with craniosynostosis may be a clinically useful biomarker by PHOMS.

The following is a summary of “Racial and Ethnic Disparities at Enrollment in DRCRnet Clinical Trials for Diabetic Macular ...

NAION is a condition that causes sudden vision loss in one eye due to reduced blood flow to the optic nerve. The damaged ...

Eye Health America expands its reach in Florida with acquisition of Quigley Eye Specialists, adding 10 clinics and 2 ASCs to their growing network.